Skip to main content
PMC home page
Radiation Oncology (London, England) logoLink to Radiation Oncology (London, England)
. 2023 Dec 12;18:199. doi: 10.1186/s13014-023-02377-3

Correction: Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study

Taro Shibuki 1,✉, Mitsuhito Sasaki 1, Shota Yamaguchi 1, Kanae Inoue 1, Tomonao Taira 1, Tomoyuki Satake 1, Kazuo Watanabe 1, Hiroshi Imaoka 1, Shuichi Mitsunaga 1, Takeshi Fujisawa 2, Kento Tomizawa 2, Hidekazu Oyoshi 2, Masaki Nakamura 2, Hidehiro Hojo 2, Masafumi Ikeda 1
PMCID: PMC10717781  PMID: 38111062

Radiation Oncology (2023) 18:178

10.1186/s13014-023-02367-5

After publication of this article [1], the authors reported that in this article the graphics relating to Figs. 1, 2, 3 and 4 captions had been interchanged; the figures should have appeared as shown below.

Fig. 1.

Fig. 1

Open in a new tab

A Typical clinical target volume (red line) and planning target volume (purple line). B Dose distribution with clinical target volume (red line) and planning target volume (purple line)

Fig. 2.

Fig. 2

Open in a new tab

Flow diagram of enrollment of the study patients

Fig. 3.

Fig. 3

Open in a new tab

A Hemoglobin levels before and after palliative radiotherapy. B The volume of red blood cell transfusion before and after palliative radiotherapy

Fig. 4.

Fig. 4

Open in a new tab

Kaplan?Meier curves of OS in patients with unresectable PC who received PRT for tumor bleeding. OS overall survival, CI confidence interval, HR hazard ratio, NE not evaluable

The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13014-023-02367-5.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Shibuki T, Sasaki M, Yamaguchi S, et al. Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study. Radiat Oncol. 2023;18:178. doi: 10.1186/s13014-023-02367-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Radiation Oncology (London, England) are provided here courtesy of BMC

RESOURCES